Verano Holdings
Top-tier MSO with strong presence in Illinois and New Jersey. Redomiciled from BC to Nevada in Nov 2025.
Analyst Coverage
Cannabis Investor News in-house rating · cin-analyst-v1.0
Verano Holdings earns a Neutral rating with a 51.6 composite score and low conviction of 1/5. Fundamentals provide the principal support at 71.0, driven by gross-margin and operating-margin subscores of 83.9 and 81.8, respectively, alongside a 90.0 cash-runway subscore reflecting positive EBITDA despite a net loss. Regulatory contributes a middling 49.0, supported by an 80.0 enforcement subscore but restrained by a 25.0 cadence subscore. Market scores 40.0 because no quote is available, while editorial ranks weakest at 30.0 amid no newsroom or brief activity. The resulting pillar mix places the shares squarely in the Neutral band rather than establishing a stronger directional case.
Licensed fundamentals data show year-over-year revenue contracting by approximately 0.8%, limiting the benefit from a gross margin just above 50.3% and an operating margin near 6.3%. EBITDA stands near $195.8 million, but the roughly $264.2 million net loss keeps the financial condition stretched and prevents operating profitability from translating into bottom-line strength. Market capitalization is approximately $419.1 million. Primary regulatory filings show the latest filing dated June 23, 2026, with no events during the latest 90-day period and two across 180 days. No enforcement hits support the regulatory pillar, although sparse filing cadence caps its contribution. Institutional pricing feeds provide no current quote, and CIN newsroom coverage records no qualifying news or brief hits, explaining the subdued market and editorial pillars.
The forward catalyst rests on fundamentals, particularly the durability of the company’s margin profile. Gross and operating profitability already represent the strongest measurable drivers, creating scope for a higher composite if revenue contraction reverses and EBITDA begins translating into materially improved net income. Greater filing frequency could reinforce visibility, but regulatory, market, and editorial scores presently lack enough strength to lead a rerating. The stretched condition keeps attention fixed on earnings conversion rather than EBITDA alone. The single most important signal to watch is whether the next primary regulatory filing shows renewed year-over-year revenue growth while preserving the current gross-margin profile.
- IR email
- investors@verano.com
- IR page
- Investor relations
- Headquarters
- 224 W HILL STREET, SUITE 400, CHICAGO, IL, 60610
- Phone
- 312-265-0730
- CEO
- George Archos
- CFO
- Richard Tarapchak
- Auditor
- required
- SEC CIK
- 1848416
- Website
- Company website
- Market cap
- $419.1M
- Enterprise value
- $849.3M
- Price to book
- 0.63
- Price to sales
- 0.51
- EV / EBITDA
- 36.79
- Revenue (TTM)
- $819.9M
- Gross profit (TTM)
- $412.9M
- EBITDA
- $195.8M
- Operating margin
- 6.3%
- Profit margin
- -32.2%
- Rev growth YoY
- -0.8%
- Return on equity
- -32.5%
- Return on assets
- 2.5%
- EPS (TTM)
- $-3.65
- EPS est. current year
- $-0.95
- Wall St. target price
- $25.00
- Shares outstanding
- 73.9M
- Insider ownership
- 14.3%
- Institutional ownership
- 0.3%
- Beta
- 1.40
- Full-time employees
- 3,800
- GICS sector
- Healthcare
- GICS industry
- Drug Manufacturers - Specialty & Generic
- Annual report
- Latest 10-K
- Proxy statement
- Latest DEF 14A
- Filing portal
- SEC EDGAR
Help us keep coverage accurate. Submit an update for CIN editorial review.
Bullish and Bearish Analyst Opinions for Verano Holdings (VRNO)
Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for Verano Holdings (VRNO), a cannabis-sector equity listed on OTCMKTS in the US MSO category. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.
CIN editorial stance: Risk Elevated. Headwinds: deep drawdown, net loss. (1 bullish signal, 3 bearish signals.)
Top-tier MSO with strong presence in Illinois and New Jersey. Redomiciled from BC to Nevada in Nov 2025.
Historical Price Data
5-year weekly price history, intraday quotes, and 52-week range for VRNO are maintained by Cannabis Investor News and refreshed throughout the trading day.